Concepedia
Statistics
Publications
14
Citations
381
H-Index
12
Active since
1992
Affiliations
Incyte (United States)(Current)
Experimental Station
Pfizer (United States)
Bristol-Myers Squibb (United States)
Bristol-Myers Squibb (Germany)
Changsheng Zheng is an author at Incyte (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.
Publications per year
1992–2020
Discovery of CC Chemokine Receptor-3 (CCR3) Antagonists with Picomolar Potency
George V. De Lucca, Ui Tae Kim, Brian J. Vargo et al. · Journal of Medicinal Chemistry · 2005 · 62 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +15
Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist
Chu‐Biao Xue, Hao Feng, Ganfeng Cao et al. · ACS Medicinal Chemistry Letters · 2011 · 48 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +17
Discovery of INCB8761/PF-4136309, a Potent, Selective, and Orally Bioavailable CCR2 Antagonist
Chu‐Biao Xue, Anlai Wang, Qi Han et al. · ACS Medicinal Chemistry Letters · 2011 · 46 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +9
Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2
Chu‐Biao Xue, Anlai Wang, David Meloni et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 41 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +6
Asymmetric reduction of aliphatic and cyclic ketones with secondary alcohol dehydrogenase from Thermoanaerobacter ethanolicus: effects of substrate
Changsheng Zheng, Viet Van Pham, Robert S. Phillips · Catalysis Today · 1994 · 31 citations
Life Sciences, Biochemistry, Microbiology +15
1–5 of 14